IDH1 and central nervous system cancer: As shown in Figure 5, after the clinical factors were adjusted, including age, gender, WHO grades, and 1p/19q status, the four-lncRNA signature was an independent prognostic factor in IDH mutant glioma patients in CGGA RNAseq dataset, TCGA dataset, GSE dataset, and CGGA microarray dataset.